Skip to main content

Advertisement

Table 1 Donor details

From: ACE2 gene expression is up-regulated in the human failing heart

Group Donor Sex Age LVEF (%) Therapeutic history
Cont (BT) 1 F 42 N/A N.K.
Cont (SAH) 2 F 48 N/A N.K.
Cont (SAH) 3 F 51 N/A N.K.
Cont (HT) 4 M 31 N/A N.K.
Cont (SEP) 5 F 3 N/A N.K.
Cont (SAH) 6 M 25 N/A N.K.
Cont (HT) 7 F 23 N/A A-DE; A-DI; BET; SYM
Cont (SAH) 8 M 25 N/A N.K.
Cont (SAH) 9 M 50 N/A N.K.
IDC 10 M 49 11 ACE; CAL; DIG; DIU
IDC 11 M 64 17 ACE; A-CO; CAL; DIG; DIU; NIT
IDC 12 M 19 N/A LVAD
IDC 13 M 41 5 A-AR; ACE; A-CO; A-IN; DIU
IDC 14 M 58 24 ACE; A-CO; ALD; DIU; XAN
IDC 15 M 52 28 A-AR; ACE; A-HI; AST; DIU;
IDC 16 M 17 N/A LVAD. DIU; SYM
IDC 17 M 56 16 ACE; A-CO; A-IN; DIG; DIU
IDC 18 M 17 N/A ACE; DIU; PDE; SYM
IDC 19 F 58 20 ACE; A-CO; DIU; NIT
IDC 20 M 51 27 A-CO; ALD; ANG; DIU;
ICM 21 F 60 25 ACE; DIG; DIU; LIP
ICM 22 M 48 15 ACE; A-CO; DIU;
ICM 23 F 51 57 A-IN; BET; CAL; LIP; NIT
ICM 24 M 56 13 ACE; A-DI; A-IN; DIU; LIP
ICM 25 M 54 21 A-AR; ACE; A-IN; DIG; DIU; LIP
ICM 26 M 56 30 A-HI; A-IN; DIU
ICM 27 F 55 N/A ACE; A-DE; A-DI; ALD; DIU
ICM 28 M 48 15 ACE; DIU; LIP
ICM 29 F 62 20.5 A-AR; ACE; ALD; A-IN; DIU; LIP
ICM 30 M 56 18 A-NE; DIG; DIU
ICM 31 M 56 N/A A-CO; ALD; ANG; DIG; DIU; LIP
ICM 32 M 50 10 ACE; A-CO; ALD; DIG; DIU
  1. LVEF, Left ventricular ejection fraction. Cont, Control (cause of death is shown in parentheses); IDC, idiopathic dilated cardiomyopathy; ICM, ischemic cardiomyopathy; BT, brain tumour; SAH, subarachnoid haemorrhage; HT, head trauma; SEP, sepsis following rupture of appendix. N/A, not available. LVAD, Left ventricular assist device. N.K., Not known. ACE, ACE inhibitor; ALD, Aldosterone antagonist; A-AR, Anti-arrhythmic; A-CO, Anti-coagulation; A-DE, Anti-depressant; A-DI, Anti-diabetic; A-HI, Anti-histamine; A-IN, Anti-inflammatory; A-NE, Anti-neoplastic; ANG, Angiotensin II receptor antagonist; AST, Asthma treatment; BET, Beta blocker; CAL, Calcium channel blocker; DIG, Digoxin; DIU, Diuretic; LIP, Lipid lowering agent; NIT, Nitrate; PDE, PDE III inhibitor; SYM, Sympathomimetic; XAN, Xanthine oxidase inhibitor.